Your browser doesn't support javascript.
loading
The increased frequency of methicillin-resistant Staphylococcus aureus with low MIC of beta-lactam antibiotics isolated from hospitalized patients.
Iwata, Yasunori; Sakai, Norihiko; Yoneda, Ikuko; Satou, Kenji; Furuichi, Kengo; Senda, Yasuko; Sakai-Takemori, Yukiko; Wada, Taizo; Fujita, Shinichi; Ogura, Hisahiro; Sato, Kouichi; Minami, Taichiro; Yamaguchi, Kaori; Kitajima, Shinji; Toyama, Tadashi; Yamamura, Yuta; Miyagawa, Taro; Hara, Akinori; Shimizu, Miho; Sakai, Yoshio; Ikeo, Kazuho; Shichino, Shigeyuki; Ueha, Satoshi; Nakajima, Takuya; Matsushima, Kouji; Wada, Takashi.
Afiliação
  • Iwata Y; Division of Infection Control, Kanazawa University, Kanazawa, Japan; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan. Electronic address: iwatay@staff.kanazawa-u.ac.jp.
  • Sakai N; Division of Blood Purification, Kanazawa University, Kanazawa, Japan; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Yoneda I; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Satou K; Faculty of Electrical and Computer Engineering, Kanazawa University, Kanazawa, Japan.
  • Furuichi K; Division of Nephrology, Kanazawa Medical University School of Medicine, Ishikawa, Japan.
  • Senda Y; Division of Infection Control, Kanazawa University, Kanazawa, Japan.
  • Sakai-Takemori Y; Division of Infection Control, Kanazawa University, Kanazawa, Japan.
  • Wada T; Division of Infection Control, Kanazawa University, Kanazawa, Japan; Department of Pediatrics, Kanazawa University, Kanazawa, Japan.
  • Fujita S; Division of Infection Control, Kanazawa University, Kanazawa, Japan.
  • Ogura H; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Sato K; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Minami T; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Yamaguchi K; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Kitajima S; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Toyama T; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Yamamura Y; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Miyagawa T; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Hara A; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Shimizu M; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Sakai Y; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
  • Ikeo K; Laboratory of DNA Data Analysis, National Institute of Genetics, Shizuoka, Japan.
  • Shichino S; Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Noda, Japan.
  • Ueha S; Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Noda, Japan.
  • Nakajima T; Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Noda, Japan.
  • Matsushima K; Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Noda, Japan.
  • Wada T; Department of Nephrology and Laboratory Medicine, Division of Blood Purification, Kanazawa University, Kanazawa, Japan.
J Infect Chemother ; 26(6): 604-610, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32094050
Methicillin-resistant Staphylococcus aureus (MRSA) causes severe infectious diseases and can be life-threatening in healthcare-settings. MRSA is classified into health-care associated (HA)-MRSA strains and community acquired (CA)-MRSA strains based on genotype and phenotype. CA-MRSA has been reported to show the lower minimal inhibitory concentration (MIC) of some antibiotics as compared to HA-MRSA. Recently, the prevalence of CA-MRSA has been increased in worldwide. CA-MRSA is isolated not only from the healthy individuals in a community but also from the patients in healthcare settings. However, the changing trend in frequency of HA-MRSA and CA-MRSA in the hospital setting is not clear. Therefore, we analyzed the trend of MIC to speculate the frequency of HA-MRSA and CA-MRSA in the facility. Moreover, gene mutations were evaluated on resistant gene loci with next generation sequencer. The frequency of strains with low MIC of beta-lactam antibiotics was gradually increased in isolated MRSA strains from the hospitalized patients. Whole genome analysis revealed the frequency of gene mutation was also decreased in some resistant loci, such as blaZ and blaR1. These findings highlight the changing trend of MRSA strains isolated from hospitalized patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Farmacorresistência Bacteriana Múltipla / Beta-Lactamas / Staphylococcus aureus Resistente à Meticilina Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Farmacorresistência Bacteriana Múltipla / Beta-Lactamas / Staphylococcus aureus Resistente à Meticilina Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article